Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

AI reads your Heart's electrical signals to find hidden blockages

NCT ID NCT06528821

Diagnosis Sponsor: Powerful Medical Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study enrolls 800 patients having heart attacks to test an artificial intelligence model that reads standard 12-lead ECGs. The AI aims to detect which artery is blocked and how severely blood flow is reduced, at the moment of a heart catheterization. If accurate, this could help doctors decide on treatment faster and more precisely.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Artificial intelligence (AI) model analyzing standard 12-lead electrocardiograms (ECGs)
What this could lead to
If successful, this AI could help doctors quickly identify which artery is blocked during a heart attack, leading to faster, more targeted treatment.
What could go wrong
This is an observational registry, not a treatment trial. The AI's accuracy may vary across different patient groups, and it has not yet been tested in real-time clinical decision-making.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 800 people

The number the study aims to enrol. It can still change while the study runs.

Started

Dec 2024

Expected to finish

May 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Adults (18 or older) with acute coronary syndrome undergoing clinically indicated invasive coronary angiography, with a standard 12-lead ECG performed at invasive coronary angiogram before percutaneous coronary intervention (maximum within 15 min before vascular access)

Ages

18 to 85 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients with acute coronary syndromes undergoing invasive coronary angiography as clinically indicated. * Availability of a standard 12-lead ECG performed at invasive coronary angiogram before percutaneous coronary intervention (maximum within 15 min before vascular access). * Age ≥18 years. Exclusion Criteria: * Individuals presenting for a non-emergent (elective) cardiac catheterization. * Individuals presenting with chronic coronary syndrome (CCS) or stable angina symptoms. * Individuals without symptoms suspicious for acute coronary syndromes. * Individuals with contraindications for cardiac catheterization.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Acute coronary syndrome are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

acute coronary syndrome acute myocardial infarction acute subendocardial myocardial infarction Coronary Occlusion coronary thrombosis intermediate coronary syndrome myocardial infarction Non-ST Elevated Myocardial Infarction ST-elevation myocardial infarction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Acute coronary syndrome Coronary occlusion Coronary syndrome NSTEMI Nstemi - non-ST segment elevation mi STEMI

Contacts and locations

Locations

  • AZ Sint Jan

    Bruges, Belgium

  • Jessa Ziekenhuis

    Hasselt, Belgium

  • LKH Hochsteiermark, Standort Bruck

    Bruck an der Mur, Austria

  • LKH II Standort West

    Graz, 8020, Austria

  • Medical University of Graz

    Graz, Austria

  • OLV Aalst

    Aalst, Belgium

  • San Pietro Hospital

    Rome, Italy

  • Sant´Andrea Hospital

    Rome, Italy

  • University Hospital D'Annunzio Chieti

    Chieti, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.